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The etiology of Kawasaki disease remains unknown despite extensive studies. Some researchers suggest that it is caused by an
infectious agent. This is a case report where a patient with incomplete Kawasaki disease was found to have evidence compatible
with acute Mycoplasma pneumoniae infection. This is one of the several case reports linking Mycoplasma pneumoniae to Kawasaki
disease as a possible trigger. This is perhaps due to a superantigen or is mediated by some other mechanism. Accurate and timely
testing for Mycoplasma infections is diﬃcult and has its limitations. Despite this, Mycoplasma pneumoniae should be considered in
the diﬀerential and workup for Kawasaki disease.
1.Case
A previously healthy, fully vaccinated 12-year-old Hispanic
male presented with a 6-day history of high-grade and inter-
mittent daily fever (up to 105◦F) upon admission. His initial
symptomsweresorethroat,nausea,andvomitinginaddition
to fever. Three days prior to admission, the patient was seen
in a pediatric emergency department and discharged with a
diagnosis of viral illness. The fever persisted, and he became
moreillappearingwithcomplaintsofweakness,malaise,and
myalgias, and a faint generalized, nonpruritic rash began to
appear. There was no history of joint involvement, sick con-
tacts, recent travel, or exposures other than a family dog.
Physical examination at the time of admission revealed a
tachycardic (heart rate of 118beats/min), tachypneic (respi-
ratoryrateof20/min),febrile(101.5◦F),ill-appearingpatient
withnormalbloodpressure(121/75).Anerythematousmac-
ular rash was present on the face, abdomen, and extremities.
He had conjunctival injection and pharyngeal erythema
without observed oral ulcers. Small bilateral cervical lym-
phadenopathy were palpated and measured to be less than
1.5cm in size. There was no associated edema, erythema, or
desquamation of the hands or feet.
Laboratory workup was initiated for suspected infecti-
ous or rheumatologic causes. Abnormal laboratory ﬁnd-
ings included a leukocytosis (17 × 103/mm3)w i t hp r e d o m -
inant neutrophils and a normocytic, normochromic ane-
mia (12.2mg/dL). Complete blood count showed an initial
thrombocytopenia (143 × 103/mm3) that was later followed
by thrombocytosis (398 × 103/mm3). In addition, analysis
revealed an elevated CRP (14.2mg/L), ESR (64mm/h), and
hypoalbuminemia (2.5g/dL). Mycoplasma pneumoniae IgM
serology was positive (Mycoplasma IgM titer ≥1.10). Chest
X-ray showed faint bilateral interstitial markings without
lung consolidation or collapse. Comprehensive viral studies
and cultures from the throat, urine, and blood were negative.
The remainder of the initial workup, which included elec-
trolytes, urinalysis, renal function test, and lupus analyzer,
w a sw i t h i nn o r m a lr a n g e .
A diagnosis of viral syndrome was initially suspected,
although a course of azithromycin (10mg/kg/day) was start-
ed. Acute Mycoplasma pneumoniae infection was made after
the Mycoplasma IgM serology came back positive. Subse-
quently, the possibility of Incomplete Kawasaki disease was
entertained given the patient’s presentation. This was later
conﬁrmed on day 1 of hospitalization by an echocardiogram2 Case Reports in Medicine
Table 1: First hospital admission inpatient course.
Day −3 Day 0 Day 1 Day 4 Day 6 Day 9
Symptoms/signs Vomiting, ST∗1,
fever, malaise Fever/rash Fever/rash Afebrile Fever Afebrile/DC∗7
WBC count, ×103 cells/µL 7.7 10.4 9.3 16.8
Hemoglobin, g/dL 12.2 12.4 10.4 8.9
Platelet count, ×103 platelets/µL 147 243 256 398
ESR, mm/h 64 145 92
CRP, mg/dL 14.2 10.1 7.4 4.3
Mycoplasma IgM Positive
Other RST Neg∗2/MST
Neg∗3 Albumin 2.5 Bld cx-neg∗4 Bld cx-neg
Echo Dilatation of RCA∗5 New ectasia
Treatment Tylenol Azithromycin IVIG and ASA∗6 2nd IVIG/ASA Prednisone/ASA
ASA and
prednisone
tapering
∗1sore throat/∗2rapid strept test negative/∗3m o n o n u c l e o s i ss p o tt e s tn e g a t i v e / ∗4blood culture negative/∗5right coronary artery/∗6aspirin/∗7discharge.
showing mild dilatation of right coronary artery. The patient
was immediately started on an IVIG (2gm/kg) infusion and
high-dose aspirin (20mg/kg/dose every 6hrs).
The patient continued to spike fevers for three days after
IVIG infusion. A second dose of 1gm/kg IVIG infusion was
given, but the inﬂammatory markers remained elevated and
the patient continued to spike fevers throughout. A repeat
echocardiogram on day 6 of hospitalization showed pro-
gression of the disease with the addition of left main and
proximal left anterior descending artery ectasia. Because of
the apparent progression of the disease, pulse therapy with
IV methylprednisolone (30mg/kg) was administered. The
patient’s symptoms improved signiﬁcantly with resolution
of the fever. The patient was discharged on day 9 of hos-
pitalization with aspirin and a prednisone tapering regimen
(Table 1).
Five days after discharge from the hospital, the patient
was readmitted due to recurrence of the fever, malaise, and
generalized erythematous rash without any new attributa-
ble exposure. Inﬂammatory markers were elevated, but im-
proved when compared to previous results. Prior discharge
medications,aspirinandprednisone,werecontinued,andan
inﬂiximab infusion (5mg/kg) was initiated. The patient re-
mained febrile, and a second IV methylprednisolone pulse
dose(30mg/kg)wasgivenafterwhichthepatientdefervesced
and improved. The patient was discharged home to continue
a prednisone tapering and aspirin regimen (Table 2).
The patient was then followed in the outpatient setting
and has had no recurrence of symptoms. A repeat echocar-
diogram 10 days after discharge showed the diameter of the
right coronary artery to be in the upper limits of normal, but
the left main and descending arteries were more dilated and
prominent.Aone-monthfollow-upechocardiogramshowed
complete resolution of the coronary arteries. Repeat Myco-
plasma IgM serology drawn ten months after discharge was
negative (Mycoplasma IgM titer ≤0.90).
2. Discussion
Kawasaki disease (KD) is an acute, self-limiting vasculitis of
unknown etiology that usually occurs in childhood between
the ages of two to ﬁve years old [1]. When untreated, 15 to
25% of patients develop coronary artery aneurysms [2]. It is
diagnosed according to the clinical criteria developed by
Kawasaki [3], as shown in Table 3. Some patients do not ful-
ﬁllthe clinical criteria forclassicKD andarediagnosed based
on echocardiogram ﬁndings. Such patients are diagnosed
with “incomplete” KD. Such patients are usually at extreme
of ages and are at more risk for developing coronary artery
disease. They may also have unusual ﬁndings and manifesta-
tions such as thrombocytopenia and hypoalbuminemia.
Because of the prolonged history of unexplained fever,
rash, bilateral conjunctival injection, and pharyngeal ery-
thema, incomplete Kawasaki disease was considered in the
case patient. Bilateral lymphadenopathy was present but no
cervical lymph node measured 1.5cm or greater. The patient
presented with three out of the ﬁve principal diagnostic
criteria along with prolonged fever characteristic of classic
Kawasaki disease (Table 3). The diagnosis was conﬁrmed
sonographically with involvement of the coronary arteries.
Many characteristics of Kawasaki disease suggest that it is
causedbyaninfectiousprocesssuchasitsself-limited,gener-
ally nonrecurring nature, fever, and localized outbreaks [2].
It is hypothesized that the vasculitis in KD may be triggered
by an immune response to a superantigen (SAg) from an in-
fectious pathogen in those who are genetically susceptible
[4]. Numerous studies showed a skewed T-cell repertoire in
KD patients, and animal models have demonstrated hall-
marks of superantigen-mediated response. Many of the in-
fectious agents linked to KD such as Staphylococci species
share the presence of superantigenic activity [5].
There is limited evidence that Mycoplasma species might
be a trigger pathogen, or at least one of them. It has been
reported on several occasions that MP infection precededCase Reports in Medicine 3
Table 2: Second admission inpatient hospital course.
Day 0 Day 1 Day 3 Day 4 F/U∗5 F/U∗6
Symptoms/signs Fever/rash/malaise Fever Fever Afebrile/DC∗3 Asx∗4 Asx
WBC count, ×103 cells/µL1 4 5 . 2
Hemoglobin, g/dL 8.9 12.5
Platelet count, ×103 platelets/µL 350 253
ESR, mm/h 115 108 124 31
CRP, mg/dL 1.4 3.3 1.7 <0.5
Mycoplasma IgM Negative
Other Albumin 2.5 Bld cx-neg∗2 Bld cx-neg
Echo
Improved
RCA∗7 diameter,
but more dilated
LMCA∗8
Normal
Treatment ASA∗1 Prednisone/ASA Inﬂiximab/ASA ASA and
prednisone tapering ASA None
∗1aspirin/∗2bloodculturenegative/∗3discharge/∗4asymptomatic/∗5followupafter10daysfromdischarge/∗6followupafter10monthsfromdischarge/∗7right
coronary artery/∗8left main coronary artery.
Table 3: Classic Kawasaki disease clinical diagnostic criteria.
Clinical criteria What did the case patient have?
Fever for ≥5 days plus 4 of the following must be present to
make a deﬁnitive diagnosis: No (patient presented with fever for ≥5 with only 3 of the following)
Polymorphous rash Yes
Bilateral conjunctival injection Yes
At least one of the following:
(i) Erythema or ﬁssuring of the lips
(ii) Strawberry tongue Yes
(iii) Diﬀuse injection of oral and pharyngeal mucosa
Acute, nonpurulent cervical lymphadenopathy (at least one
node ≥1.5cm) No
At least one of the following:
(i) Erythema of palms and soles
(ii) Indurative edema of hands and feet No
(iii) Membranous desquamation from ﬁngertips
classic KD [6]. MP has been reported to cause cutaneous
vasculitis by immune-complex-mediated mechanisms [7].
Another species of the Mycoplasma genome, Mycoplasma ar-
thritidis, has been shown to produce a superantigen sug-
gesting the possibility that other Mycoplasma species may do
likewise [8].
ThepatienthadserologicevidenceofacuteMPinfection.
To the best knowledge of the writers, this is the ﬁrst case
reportofMPinfection,oratleastevidenceofacuteinfection,
followed by incomplete KD.
Diagnosing MP is a diﬃcult task, especially in the face of
Kawasaki disease. It is hampered by lack of standardized,
rapid, and speciﬁc methods. Laboratory tests for MP include
culture, serology, and PCR. There is a high ratio of asymp-
tomatic respiratory carriers, and because of continued car-
riage of the organism after infection and treatment, PCR and
culturesfromrespiratorytractspecimenscarrytheriskofde-
tecting healthy carriers. In recent years, the diagnosis of MP
has relied mostly on serological methods.
Given the simplicity and benign treatment for MP infec-
tion, many clinicians use single-point Mycoplasma IgM se-
rology testing to determine treatment instead of the “gold
standard” paired sera conversion test. IgM antibodies are
usuallyproducedacutely,andraisedIgMlevelsindicateacute
infection. However, it was observed that elevated levels of
Mycoplasma IgM might persist for several years raising con-
cern for false-positive results [9]. When only one is positive,
antibiotics are generally given as treatment, however, a sec-
ond sample is ideally required to conﬁrm. In this patient,
repeat anti-Mycoplasma level IgM test ten months after in-
itial diagnosis was negative favoring a true-positive initial
test.
MP infection can present similarly to KD with prolonged
fever,rash,conjunctivitis,andlymphadenopathy,andcertain4 Case Reports in Medicine
species of Mycoplasma genome are known to form super-
antigen. In this patient, initial Mycoplasma IgM titer at pres-
entationwaspositive andrepeatMycoplasmaIgMtiterserol-
ogy was negative, favoring a true positive test at initial KD
presentation. To elucidate a true relationship, if any, between
Mycoplasma infection and KD, Mycoplasma testing should
be considered in patients found to have KD when clinically
suspected which may ultimately aﬀect severity of disease,
prognosis, and treatment. The type of testing to pursue to
determine acute Mycoplasma infection in the face of KD,
however, remains a dilemma.
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